"Our goal at the APA is to provide access to beneficial products and services for independent and small chain pharmacies, their customers, and software vendors nationwide." said John Hobson, APA's Director of Business Development. "We want to ensure access to those programs that provide significant benefits, and the Pleio GoodStart® program has been proven to improve quality and increase revenue."
Mark Connors, CEO of Pleio, said, "We're extremely excited about the expansion of our relationship with the APA and our partnership with PDN. With over 12,000 independent pharmacies served by its industry leading software vendors, this support represents a huge opportunity to broaden our network in order to improve Star ratings and quality scores for community pharmacy."
About Pleio, Inc.
Pleio is a leader in patient engagement and medication adherence. We instill lasting behavior change in patients though multi‐channel engagement involving artfully scripted, non‐clinical conversations with GoodStart Mentors™, digital outreach, and seamless integration with community pharmacy. Pleio's proprietary adherence lifecycle management platform controls the timing and nature of all patient touch points in the GoodStart™ program, which delivers revenue, improves quality, and reduces medical costs.